The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369

GRADE guidelines: 3. Rating the quality of evidence

Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285

Clinical Practice Guidelines We Can Trust

Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,146

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III

Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial

Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930

GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength

Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,366

Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines

Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220

Economic costs of excessive alcohol consumption in the U.S., 2006

Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.045 · Cited by 1,041 · cited 1×

Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty

Mark, T. L., Kassed, C. A., Vandivort-Warren, R., Levit, K. R., & Kranzler, H. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.018 · Cited by 246

Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group.

(1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.631 · Cited by 205

Investigation and analysis of factors related to sleep conditions during the acute withdrawal period of alcohol use disorder

Liu, X., Kong, X., & Chen, X. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1469324 · Cited by 3

Trends in Newly Filled GLP-1 Receptor Agonist Prescriptions for US Patients With Versus Without Comorbid Alcohol Use Disorder, 2016–2024

Wallach, J. D., O’Malley, S. S., Lipska, K. J., Ross, J. S., Jeffery, M. M., & Savitz, S. T. (2025) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001575 · Cited by 3

Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023

Ellis, M. S., Whitley, P., & Passik, S. D. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113020 · Cited by 3

Naltrexone Is Superior to Placebo for Abstinence and Craving Reduction in Alcohol‐Associated Cirrhosis: NAL ‐ CI Trial

Alla, M., Varshney, M., Bhardwaj, A., Kumar, G., Shasthry, S. M., & Sarin, S. K. (2026) · Liver International · doi:10.1111/liv.70845 · Cited by 3

Pharmacotherapy and gambling disorder: a narrative review

Farkouh, R., Audette-Chapdelaine, S., & Brodeur, M. (2023) · Journal of Addictive Diseases · doi:10.1080/10550887.2023.2229725 · Cited by 3

Baclofen for the Treatment of Alcohol Use Disorder

Agabio, R., Rolland, B., & Leggio, L. (2024) · The Receptors · doi:10.1007/978-3-031-67148-7_6 · Cited by 3

Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study

Sridharan, K. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2464896 · Cited by 3

Liver Transplant Provider Perspectives on Posttransplant Management of Alcohol Use Disorder

Cote, M. P., Cloonan, D. J., Li, S., Razak, S. S., Singh, R., Coe, T. M., Zimbrean, P. C., Andrews, S. R., Ivkovic, A., Bartels, S. J., et al. (2025) · Transplantation Direct · doi:10.1097/txd.0000000000001766 · Cited by 3

Alcohol Withdrawal Management and Relapse Prevention in Pregnancy

McDonald, P., Jia, L.-S., & Vipler, S. (2018) · Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000034 · Cited by 2

Alcohols: volatiles and glycols

Garg, U. C., & Ketha, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815846-3.00005-3 · Cited by 3

Evaluation of spin in the abstracts of systematic reviews and meta-analyses focused on treatments of alcohol use disorder

Verble, C., Cloeter, M., Ottwell, R., Arthur, W., Hartwell, M. L., Carr, B., Dunn, K. E., Baker, J., Wright, D., Sealey, M., et al. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2021.1903022 · Cited by 3

Revised Clinical Practice Guideline of Korean Pancreatobiliary Association for Acute Pancreatitis: Initial Treatment, Nutritional Support, Convalescent Treatment

Kim, E. J., Lee, J. M., & Lee, T. H. (2022) · The Korean Journal of Pancreas and Biliary Tract · doi:10.15279/kpba.2022.27.1.22 · Cited by 3

Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy

Agabio, R., Sinclair, J., Terplan, M., Traccis, F., & Minozzi, S. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015042 · Cited by 3

Online 12-step groups during the Covid-19 pandemic: A patient's perspective

Carlo, F. D. D., Alessi, M. C., Picutti, E., Pettorruso, M., Martinotti, G., & Giannantonio, M. D. (2022) · Emerging Trends in Drugs, Addictions, and Health · doi:10.1016/j.etdah.2022.100047 · Cited by 3

Alcohol Drinking, Smoking, and Diabetes

Jung, W. (2022) · Journal of Korean Diabetes · doi:10.4093/jkd.2022.23.3.192 · Cited by 3

Current treatments of alcohol use disorder

Dionisi, T., Sario, G. D., Mori, L. D., Spagnolo, G., Antonelli, M., Tarli, C., Sestito, L., Mancarella, F. A., Ferrarese, D., Mirijello, A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.02.005 · Cited by 4

Emerging GPCR targets for AUD: Insights from preclinical studies

Anversa, R. G., Barron, M. L., Walker, L. C., & Lawrence, A. J. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102896 · Cited by 3

A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease

Twohig, P. A., Balasanova, A. A., Cooper, L., Le, M., Khoury, N., Manatsathit, W., Olivera-Martinez, M. A., & Peeraphatdit, T. B. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001371 · Cited by 3

The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study

Yang, K., Kim, S. H., Yang, H., Wang, S., Jeong, B., Lim, H. K., & Bae, S. H. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0278 · Cited by 3

A randomized sham-controlled trial to study the effect of transcranial direct current stimulation on craving, abstinence, and time to relapse in severe alcohol use disorder

Joshi, T., Dhiman, V., Verma, R., Krishnan, V., Basu, A., & Singh, Y. (2025) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_744_24 · Cited by 4

Primary Care Visit Frequency Is Associated With Diagnosis But Not Pharmacotherapy Prescribing for Patients With Alcohol Use Disorder

Bishop, R. A., Ward, R. C., Schreiner, A. D., McCauley, J. L., Moran, W. P., & Ball, S. J. (2025) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-025-09942-6 · Cited by 3

Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring Change

Mathew, S. J., & Price, R. B. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19121242 · Cited by 3

New Access Routes to Undertreated Populations; How Do Problem Substance Users Recruited from an Unemployment Office Differ from Detoxification Treatment Inpatients?

Scherbaum, N., Mikoteit, T., Witkowski, L., Bonnet, U., Specka, M., Schifano, F., & Lieb, B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413014 · Cited by 2

Impact of hospital‐administered extended‐release naltrexone on readmission rates for patients with alcohol use disorder

Singh, N. M., Daniel, K., & Balasanova, A. A. (2024) · Internal Medicine Journal · doi:10.1111/imj.16467 · Cited by 2

Couple-Focused Smartphone Intervention to Reduce Problem Drinking: Pilot Randomized Control Trial

Gustafson, D. H., Gustafson, D. H., Mares, M., Johnston, D. C., Vjorn, O., Curtin, J. J., Epstein, E. E., & Bailey, G. L. (2024) · JMIR Formative Research · doi:10.2196/58622 · Cited by 5

Association of Medicare Advantage vs Traditional Medicare with Clinical Outcomes Among Patients Hospitalized for Substance Use Disorders

Bernstein, E. Y., Fu, C. X., Ayanian, J. Z., Curto, V. E., Anderson, T. S., & Landon, B. E. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09413-w · Cited by 2

Prevention of Alcohol-Associated Liver Disease

Burton, R., Leggio, L., Louvet, A., Sheron, N., & Singal, A. K. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003427 · Cited by 2

Managing treatment-resistant depression with comorbid substance use disorders

Stubbs, K. R., Bezooyen, J. V., & Tang, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00031-1 · Cited by 2

Pharmacotherapy for Alcohol Use Disorder Is Underutilized Among Commercially Insured Adults With Alcohol-Associated Liver Disease

Lieber, S. R., Jones, A. R., Jiang, Y., Tadros, M. M., Gowda, P., Bardhi, O., Tujios, S. R., Cotter, T. G., Shenoy, A., Lippe, B., et al. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100799 · Cited by 2

Evaluating the Long‐Term Benefits of Medications for Alcohol Use Disorder in Alcohol‐Associated Cirrhosis

Niu, C., Zhang, J., Idoate-Domench, D. J., Rao, A., Sanjeevi, A., Joshi, U., Zhu, K., Jadhav, N., Daglilar, E. S., & Okolo, P. I., III (2025) · Liver International · doi:10.1111/liv.70424 · Cited by 2

Treatment approaches for alcohol use disorder with metabolic dysfunction

Wagner, A. C., Jung, J., Pacher, P., & Lohoff, F. W. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108957 · Cited by 4

Predictors and barriers to minimally adequate treatment among treated individuals with mental disorders: results from the World Mental Health Surveys

Pozuelo, J. R., Vigo, D., Kazdin, A. E., Harris, M., Stein, D. J., Viana, M. C., Hwang, I. H., Kessler, T. L., Manoukian, S. M., Sampson, N. A., et al. (2025) · International Journal of Mental Health Systems · doi:10.1186/s13033-025-00686-6 · Cited by 2

Initiation of pharmacotherapy for alcohol use disorder in Japan: a longitudinal descriptive study

Kitamura, M., Fukasawa, T., Nakagami, Y., Shirakawa, S., & Kawakami, K. (2026) · Alcohol and Alcoholism · doi:10.1093/alcalc/agag005 · Cited by 2

An Emergency Department Nudge-Based Strategy to Screen and Treat Patients With Alcohol Misuse

Ebert, J. P., Huo, S. C., Perrone, J., Moon, J., Mull, N. K., Flores, E. J., Adams, L., Berk, A., Dart, H., O’Donnell, N. H., et al. (2026) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2026.03.021 · Cited by 2

Drugs for Treating Alcohol Use Disorder During Lactation

Anderson, P. O. (2022) · Breastfeeding Medicine · doi:10.1089/bfm.2022.0241 · Cited by 2

Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C

Jiang, X., Song, H. J., Chang, C., Wilson, D. L., Guo, J. S., Lo‐Ciganic, W., & Park, H. (2022) · Medical Care · doi:10.1097/mlr.0000000000001801 · Cited by 2

Substance use and related disorders among persons exposed to the 9/11 terrorist attacks: Essentials for screening and intervention

Dowling, F. G., & Lowe, S. M. (2023) · Archives of Environmental & Occupational Health · doi:10.1080/19338244.2023.2180614 · Cited by 2

Types of addiction

Turpin, M. A. C., Rowland, K. C., Anugwom, C., Arocha, M., Carona, A., Gonzalez, B. I., Iskander, G., Snyder, S., Wilson, K., Kaye, A. D., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00027-5 · Cited by 3

Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study

Snyder, S., Butala, N., WILLIAMS, A. M., & Kneebusch, J. (2024) · Pharmacy · doi:10.3390/pharmacy12010026 · Cited by 2

Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder

Bach, P., Franck, J., Hällgren, J., Widing, H., Gissler, M., & Westman, J. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-01988-z · Cited by 2

A Randomized Trial of Alcohol Telemedicine in Primary Care: Pharmacotherapy and Referral Outcomes

Sterling, S., Leibowitz, A., Satre, D. D., Cocohoba, J. M., Kline‐Simon, A. H., Weisner, C. M., Metz, V. E., Ghadiali, M., Corriveau, C., O’Malley, S. S., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09708-y · Cited by 2

Therapeutic potential of agmatine in alcohol use disorder: Preclinical insights and future directions

Dhaigude, P., Pable, A., Katariya, R., Tadas, M., Kale, M. B., Umekar, M. J., Kotagale, N. R., & Taksande, B. G. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115793 · Cited by 2

Alcohol Use Disorder in a Culture That Normalizes the Consumption of Alcoholic Beverages: The Conflicts for Decision-Making

Messas, G. P., & Soares, M. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-47852-0_19 · Cited by 2

Analyzing Therapy Logs: Mapping Physical and Mental Manifestations of Anxiety Among Children Undergoing Dance/Movement Therapy

Nardi, A. B., Engelhard, E. S., & Or, M. B. (2023) · American Journal of Dance Therapy · doi:10.1007/s10465-023-09380-x · Cited by 3

Anticraving medication for moderate to severe alcohol use disorder

Mong, J., Ahamad, K., & Bach, P. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.200895 · Cited by 2

Beyond Brief Intervention: Pharmacologic Management of Alcohol Use Disorder

Pearson, C., & Duff, E. (2019) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2019.05.015 · Cited by 2

Substance Use Disorder and HIV

Slawek, D. E., & Cunningham, C. O. (2020) · Springer eBooks · doi:10.1007/978-3-030-48744-7_10 · Cited by 2

Alcohol and Substance Use Disorders in Humanitarian Emergencies: Co-morbid Mental Disorders, Identifying Gaps and Emerging Trends

Jegede, O. O. (2022) · Environment and Social Psychology · doi:10.18063/esp.v7.i1.684 · Cited by 1

Drugs Used in Withdrawal Management and Post-Withdrawal Management

Weaver, M. F., Hong, J. H., & Gilmore-Thomas, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-18381-2_19 · Cited by 1

Non-pharmacotherapeutic Management of Alcohol Use Disorder in the Alaska Native Population: A Narrative Review

Godbole, N. B., Dave, U., Lewis, E., Godbole, N., Sullivan, G., & Schultz, A. (2023) · Cureus · doi:10.7759/cureus.39090 · Cited by 1

Alcohol and Drug Use Disorders

Baca-Atlas, M., Baca-Atlas, S. N., & Fedoriw, K. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-29171-5_6 · Cited by 1

Management of Patients After Treatment of Severe Alcohol-associated Hepatitis

Shetty, A., Ibrahim, B., Eskander, B., & Saab, S. (2023) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001882 · Cited by 1

Störungen durch Substanzkonsum oder abhängige Verhaltensweisen

Pogarell, O. M., Lieb, K., Turner, D., & Tüscher, O. (2023) · Elsevier eBooks · doi:10.1016/b978-3-437-23492-7.00013-6 · Cited by 1

Concurrent opioid and alcohol withdrawal management

Colvard, M. D. (2023) · Mental Health Clinician · doi:10.9740/mhc.2023.12.268 · Cited by 1

Quality of Life among Patients with Substance Induced Psychosis

mostafa, N., Ibrahim, N., & El-bilsha, M. A. (2023) · Mansoura Nursing Journal · doi:10.21608/mnj.2023.340501 · Cited by 1

Alcohol Consumption Among Persons Living with HIV: Perceptions, Messages and Interventions—A Qualitative Study at an HIV Treatment Clinic in South Western Uganda

Asiimwe, S. B., Kekibiina, A., Woolf‐King, S. E., Fatch, R., Emenyonu, N. I., & Hahn, J. A. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04377-0 · Cited by 1

Disulfiram Should Remain Second-line Treatment for Most Patients with Alcohol Use Disorder.

Axelrath, S. (2024) · Journal of addiction medicine · doi:10.1097/adm.0000000000001360

The trajectory of substance use disorder among people formerly in foster care: A survival analysis

Olamazadeh, S., Hassan, A. N., & Foll, B. L. (2024) · International Journal of Social Psychiatry · doi:10.1177/00207640241287088 · Cited by 1

Alcohol-associated liver disease

Singal, A. K., Mehta, H., Clemente, A. P. G., Arab, J. P., Dunn, W., & Bataller, R. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26711-6.00028-7 · Cited by 1

Post-transplant complications in alcohol- and metabolic-associated steatotic liver disease

Jadaun, S. S., & Saigal, S. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.62 · Cited by 1

Review of acamprosate pharmacokinetics and dosing strategies

Steil, L., Terasaki, D., Reiss, R., & Deaney, M. A. (2025) · Mental Health Clinician · doi:10.9740/mhc.2025.04.056 · Cited by 1

A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder

Srivastava, A. B., & Gold, M. S. (2025) · Brain Sciences · doi:10.3390/brainsci15111190 · Cited by 3

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease

Zhang, W., Hwang, S. Y., & Luther, J. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-01026-x · Cited by 1

Concurrent Disorders: Treatment of Comorbid Alcohol Use Disorder and Major Depressive Disorder

Primeau, V., Danilewitz, M., Crockford, D. N., Kleinman, R. A., Jutras‐Aswad, D., & Bahji, A. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251409626 · Cited by 1

Alpha-2 Adrenergic Agonists Reduce Heavy Alcohol Drinking and Improve Cognitive Performance in Mice

Quadir, S. G., Lepeak, L., Miracle, S. A., Collu, R., Velte, O., He, Y., Öztürk, Z., Rohl, C. D., Sabino, V., & Cottone, P. (2026) · eNeuro · doi:10.1523/eneuro.0368-25.2026 · Cited by 1

Impact of Pharmacist‐Led Education and Order Panel Implementation on Alcohol Use Disorder Treatment in the Primary Care Setting at a Large Academic Medical Center

Xia, W., Loeb, A., Berkley, E., Kotova, M., Fine, J., & Hoss, R. (2026) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70182 · Cited by 1

A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients

Nazon, M., Lavín, P., Pike, C. W., Greenway, K. T., Richard, J., Lespérance, P., Ostacher, M. J., Jutras‐Aswad, D., Tate, S., Lembke, A., et al. (2026) · Alcohol and Alcoholism · doi:10.1093/alcalc/agag008 · Cited by 2

Implementation of a Hospital-Based Screening and Treatment Program for Unhealthy Alcohol Use

Ramesh, J., Moriates, C. P., Embers, J., Boulton, A., Kluz, N., Holliman, R., Ibarra, F., Dede-Bamfo, O., Chang, P., Velasquez, M. M., et al. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10473-9 · Cited by 1

Use and Motivations for Consuming No and Low ( NoLo ) Alcohol Beverages Among US Adults 21 Years or Older

Westmoreland, D. A., Bleasdale, J., Kothawar, G., Scaglione, N. M., Hone, L. S. E., Bravo, A., & Cook, R. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70192 · Cited by 1

Disulfiram‐Induced Hepatotoxicity in a Patient With Alcohol Use Disorder: A Case Report

Wangchuk, S., Chhetri, B., & Loo, J. L. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73209 · Cited by 1

Medications for Alcohol Use Disorder

Holt, S. R. (2026) · JAMA · doi:10.1001/jama.2026.10575 · Cited by 1

Alcohol Use Disorders

Orsolini, L., Bellantuono, C., Berardis, D. D., & Schifano, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_19 · Cited by 1

The effects of binge drinking on healthy and diseased livers

Rumbolt, C., & Minuk, G. Y. (2021) · Canadian Liver Journal · doi:10.3138/canlivj-2020-0037 · Cited by 1

Managerhaftung und Verjährung

Baums, T. (2010) · ZHR : Zeitschrift für das gesamte Handelsrecht und Wirtschaftsrecht · Cited by 1

Substance Use and Substance Use Disorders

Mcduff, D. R., Garvin, M., & Thompson, D. L. (2022) · Springer eBooks · doi:10.1007/978-3-031-08364-8_14 · Cited by 1

Understanding Ohio X-Waivered Advanced Practice Registered Nurses’ Rate of Naltrexone Prescription for Alcohol Use Disordered Patients

Wiggins, M., Painter, S., Burant, C. J., Juratovac, E., & Alto, K. M. (2023) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903221151062 · Cited by 1

Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines

Crockford, D. N., Bahji, A., Schütz, C. G., Brasch, J. S., Buckley, L., Danilewitz, M., Dubreucq, S., Mak, M. S. B., & George, T. P. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241232456 · Cited by 1

Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report

Chowdhury, D., & McCarthy, C. M. (2024) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000599 · Cited by 1

Relapse Risk Factors Associated with Cravings in Patients with Alcohol Use Disorder

Lin, Z.-Y., Meng, S.-C., & Huang, M. (2025) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_21_25 · Cited by 1

Relationship between Medicaid coverage design and receipt of medication for alcohol use disorder (MAUD): Probability of receipt increases based on comprehensiveness of plan

Estrada, M. A. G., Steuart, S. R., Andrews, C. M., Grogan, C. M., Hinds, O. M., Lawler, E. C., Lozano-Rojas, F. A., Westlake, M. A., Peterson, L. V., Wing, C., et al. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100374 · Cited by 1

Anticonvulsants to Treat Cannabis Use Disorder

Mason, B. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_21 · Cited by 1

Medical Students and Substance Use Disorders

Kast, K. A., & Avery, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-16558-1_3 · Cited by 1

Use of Medications for the Treatment of Alcohol Dependence: A Retrospective Study Conducted in 2011-2012

Agabio, R., Balia, S., Gessa, G. L., & Pani, P. P. (2020) · Current Drug Research Reviews · doi:10.2174/2589977512666201228121820 · Cited by 1

High-Risk Behaviors

Fisher, G. L., & Roget, N. A. (2009) · doi:10.4135/9781412964500.n158 · Cited by 1

Chapter 63. Psychopharmacology During Pregnancy and Lactation

Newport, D. J., di Scalea, T. L., Richardson, E., Smith, T. L., Scott, N. P., & Stowe, Z. N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as63 · Cited by 1

Comparative effectiveness of gabapentin and pregabalin on reduction in alcohol use: A nationwide observational cohort studyPreprint

Gunawan, T., Gray, J. C., Shi, M., Wingo, T. S., Wingo, A. P., Fiellin, D. A., Tazare, J., Farokhnia, M., Leggio, L., Kranzler, H. R., et al. (2026) · medRxiv · doi:10.64898/2026.01.13.26344031 · Cited by 1

Response to: “Drugs for treatment for alcohol use disorders expose to interactions with others … for little benefit if any”

Guérzoni, S., Pellesi, L., Pini, L. A., & Caputo, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.024

Microscopes and Telescopes: the Societal Impact of Substance Use Disorder Treatment

Connery, H. S., & Weiss, R. D. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18060694

Belohnung und das Opioidsystem

Malejko, K., Graf, H., & Rau, V. (2018) · Nervenheilkunde · doi:10.1055/s-0038-1675696

The Case of Dr. Sigi Halsted: Overdose in the OR

Kast, K. A., & Avery, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-10952-3_7

Chapter 30: Toxicology

Chyka, P. A. (2018) · The American Pharmacists Association eBooks · doi:10.21019/9781582122984.ch30

Treatment management of psychoactive substance use disorders

Coman, H. G., Cozman, D., Buciuta, A., & Nemeş, B. (2019) · Psihiatru ro · doi:10.26416/psih.59.4.2019.2604

Is naltrexone an effective treatment for adults with alcohol use disorder?

Bell, T., & Leon, E. (2020) · Evidence-Based Practice · doi:10.1097/ebp.0000000000001065

Opioid Analegiscs and Drugs for Alcohol Use Disorder

Sadek, J. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-60766-1_9

Alcohol Use Disorder

Alipour, A., & Koch, J. M. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.aud_overview

Recommendations from Current German, British, American, and Australian Guidelines on Alcohol Treatment

Proebstl, L., & Pogarell, O. M. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_462-1

Des médicaments réduisant l’appétence pour l’alcool pour traiter les troubles de consommation d’alcool modérés à graves

Mong, J., Ahamad, K., & Bach, P. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.200895-f

PENERAPAN MODEL PEMBELAJARAN KOOPERATIF TIPE TAI (TEAM ASSITED INDIVIDUALIZATION) DAN TIPE STAD (STUDENT TEAMS ACHIEVEMENT DIVISIONS) DALAM PEMBELAJARAN MATEMATIKA DITINJAU DARI AKTIVITAS BELAJAR SISWA

Sukmawati, E. (2008)

Relación entre los tipos de administración desleal y apropiación indebida: interpretación doctrinal y jurisprudencial

González, O. G. (2009) · Cuadernos de Política Criminal

Abhängigkeitserkrankungen

Lieb, K., & Tüscher, O. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-23491-0.00013-0

Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association

(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1 · Cited by 88

Practice Guideline for the Treatment of Patients With Substance Use Disorders, Second Edition

(2007) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423363.141077 · Cited by 172

American Psychiatric Association Practice Guidelines

Alarcón, R. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0107 · Cited by 112

American Psychiatric Association issues guidelines on treatment of substance use disorders.

(1996) · PubMed

Pharmacological treatment of alcohol use disorder.

Mason, B. J. (2019) · American Psychological Association eBooks · doi:10.1037/0000133-022 · Cited by 1